VEGF is a key angiogenic molecule that is most frequently upregulated in tumor and immune cells [156], and several studies have demonstrated a requirement of SRC in VEGF-mediated angiogenesis by preventing endothelial cell apoptosis and influencing the stability of sprouting blood vessels [157–160]. This evidence concerns the gene SRC and neoplasm.